Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Gail Hecht MD Editor-in-Chief

Steven A. Edmundowicz MD, MASGE Associate Editor

Scott J. Cotler MD Associate Editor

See All Experts

featured

Published in Gastroenterology

Journal Scan / Research · November 11, 2020

Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression

Liver Transplantation

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

Liver Transplantation

Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial

Liver Transpl. 2020 Nov 01;26(11)1430-1440, K Bari, SA Shah, TE Kaiser, RM Cohen, N Anwar, D Kleesattel, KE Sherman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression

Additional Info

Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial

Further Reading

Final Note From the Gastroenterology Editors

Impact of Immune Checkpoint Inhibitor Therapy on Hepatitis B Surface Antigen Seroclearance in Patients With Cancer

Outcomes of Treatment With the GLP-1/Glucagon Dual Receptor Agonist Pemvidutide in Patients With MASLD

Resmetirom Therapy for the Management of Patients With MASLD: Updates to the AASLD Practice Guidance

Association Between MASLD/MetALD and Mortality Risk Among Individuals With Cardiometabolic Risk Factors

Liver Transplantation–Related Considerations in Patients With Alcohol-Associated Liver Disease

Diagnostic Stool Tests for Diarrhea

Outcomes of Using Subcutaneous Infliximab Biosimilar CT-P13 as Maintenance Therapy in Patients With IBD

Defining and Monitoring Small Bowel Strictures in Crohn's Disease on Intestinal Ultrasound

Effect of a Gluten-Free Diet on Gut Function and Microbiome in Celiac Disease

CYP2C8*3: A Protective Factor Against Post-ERCP Pancreatitis

Recently Updated